JP
AUXL

John Paulson’s AUXILIUM PHARAMCEUTICALS INC AUXL Stock Holding History

John Paulson’s Portfolio AUXL Stock Details AUXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-4,000,000
Closed -$119M – 72
2014
Q3 		$119M Hold
4,000,000
– – 0.5% 44
2014
Q2 		$80.2M Hold
4,000,000
– – 0.35% 53
2014
Q1 		$109M Buy
+4,000,000
New +$106M 0.53% 48

Other funds holding AUXL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.26B AUM 81.38% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return
MP
Manikay Partners New York $893M AUM 55.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

John Paulson's AUXL Position: Q4 2014 in Review

John Paulson sold out of AUXILIUM PHARAMCEUTICALS INC (AUXL) in Q4 2014, closing a stake of 4,000,000 shares — an estimated $119M sold.

John Paulson first reported a position in AUXL in Q1 2014 and held it in 3 quarters. The position peaked at $119M in Q3 2014. 158 funds tracked by Wall St. Rank hold AUXL as of Q4 2014.

  • John Paulson reported no remaining AUXILIUM PHARAMCEUTICALS INC position as of Q4 2014 after selling out during the quarter.
  • John Paulson sold 4,000,000 AUXILIUM PHARAMCEUTICALS INC shares in Q4 2014, an estimated $119M.
  • John Paulson first reported a position in AUXILIUM PHARAMCEUTICALS INC in Q1 2014 and held it in 3 quarters.
  • John Paulson's AUXILIUM PHARAMCEUTICALS INC position peaked at $119M in Q3 2014.
  • 158 funds tracked by Wall St. Rank held AUXILIUM PHARAMCEUTICALS INC as of Q4 2014.

Based on Paulson & Co's 13F filing for Q4 2014, filed 17 Feb 2015.